In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH: None known
PREGNANCY: There are no human or animal data available to assess the use of golodirsen during pregnancy.
The indication for golodirsen is approved under accelerated approval based on an increase in dystrophin production in skeletal muscle observed in patients treated with the drug. Continued approval for this indication may be contingent upon verification of a clinical benefit in confirmatory trials.
Please login to view the rest of this drug profile.